Lifestyle Factors and the Physical Health of Patients on Depot Antipsychotics in the Haywards Heath Catchment Area, Linwood ATS (Phase1, 2022)

AIMS/CONTEXT: Patients with severe mental illness have reduced life expectancy, representing one of the most significant health disparities. Although the cause is multifactorial, cardiovascular disease & other comorbid chronic conditions play an essential role. Individuals with mental illness often face considerable barriers to accomplishing their health and well-being goals. As a result, there is a growing interest nationally and internationally and research evidence for the role of lifestyle interventions in managing mental health conditions. NICE guidelines now reflect this, recognizing the impact of physical health comorbidity and recommending monitoring of metabolic status and cardiovascular risk (using the Q-RISK3 tool) in the management of schizophrenia & bipolar. AIMS: -Phase 1: to identify & analyse lifestyle parameters contributing to patient’' health & leading to excessive disease burden and the QRISK3 calculations for patients in the Haywards Health catchment area on depot antipsychotics. -Phase 2: make recommendations focused on lifestyle factors interventions in addition to standard care-Phase 3: to re-assess following the recommendations from phase 2. METHODS: Phase 1 Steps Identifying all patients on depot antipsychotics living in the defined catchment area. Data Collection from the electronic clinical record: diagnoses, gender, physical activity, alcohol intake, smoking, lipids, employment, BMI, blood pressure, QRISK3. Analyse results. Make Phase 1 Recommendations. Phase 2: Implement phase 1 recommendations Phase 3: Use the electronic records to conduct a second analysis assessing the offer of intervention to patients, reassessing the lifestyle parameters and QRISK3 calculation RESULTS: Phase 1 Results: All patients identified (6) had a detailed overview of the lifestyle parameters assessed. None of the patients had the QRISK®3 calculation in phase 1. CONCLUSION: A series of recommendations were made at the end of Phase 1 Disseminate results locally, including in primary care. Ascertain up-to-date information regarding physical health and lifestyle parameters in the OPC reviews; include in the letters to GP updates on the category of lifestyle parameters included in this project. Discussion with patients on the impact of lifestyle factors in the OPC reviews. Signpost patients to resources they can use to support implementing positive lifestyle choices. QRISK®3 measurement; 1:1 psychoeducational session focusing on improving lifestyle choices. Engage patients to engage in co-producing psychoeducational sessions aimed at improving lifestyle choices. Phase 2: implement phase 1 recommendations (October 2022-September 2023) Phase 3: re-assess in October 2023